LEEANN LAFONT: Open Payments
NPI 1568015949 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 27 payments from 7 companies in 2025. Trend: 2023 $438 · 2024 $1,219 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $193 |
| Regeneron Healthcare Solutions, Inc. | 6 | $167 |
| GENZYME CORPORATION | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Insmed, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, AIRSUPRA, TEZSPIRE, INSPIRE, Arikayce.
Industry payments across AL — which companies pay providers there.
